When to Use & Trade-Offs

Construction-Manager-at-Risk (CMAR) earns its reputation as the healthcare "workhorse" because it pairs early builder collaboration with design control and cost certainty — but it is not the right answer for every project. This article is a decision aid: it sets out the conditions where CMAR is the strongest fit, where another model serves better, and the honest trade-offs an owner accepts when choosing it.

CMAR fits projects where scope is complex but the owner still wants design control

CMAR is most defensible when several of the following are true at once:

The clinical program is complex or still maturing. Acute-care expansions, tower additions, surgical platforms, imaging suites, and central-utility-plant work all carry deep coordination demands across structural, MEP, medical-gas (NFPA 99), life-safety (NFPA 101), and ventilation (ASHRAE 170 / FGI Guidelines) systems. CMAR lets a builder begin scrubbing constructability and cost while the A/E is still resolving the program.
The owner wants to keep a direct relationship with the architect. Because CMAR preserves separate owner contracts with the A/E and the CM, the owner retains design authorship and the ability to drive aesthetics, standards, and clinical adjacencies — unlike design-build, where the builder holds the designer.
Early cost certainty matters more than the lowest hard bid. A board, a system capital committee, or a bond covenant often needs a reliable number before design is fully complete. CMAR's preconstruction phase produces progressively refined estimates and ultimately a Guaranteed Maximum Price (GMP), giving budget confidence well before drawings are 100% complete. (The GMP mechanics themselves are covered in the GMP & Risk Article; here the point is simply that early certainty is available.)
Schedule pressure favors overlapping design and construction. CMAR supports phased GMPs and early-release packages (site, foundations, structure, long-lead equipment) so site work and procurement can begin before the full design set is done — valuable when a service line, a regulatory deadline, or a lease expiry sets the opening date.
The market has qualified CM firms competing on capability. CMAR is a qualifications-based selection. It works best where the owner can choose among contractors with genuine healthcare depth — infection-control (ICRA) discipline, occupied-campus experience, and the bonding capacity to stand behind a GMP.

When most of these hold — large dollar value, technical complexity, a capable design team the owner wants to keep, and a need for early budget and schedule confidence — CMAR is usually the default recommendation for US hospital work.

CMAR is weaker for small, simple, or fully-defined projects

The same features that make CMAR strong on complex work become overhead on simple work. Reconsider CMAR when:

The project is small or low-complexity — a tenant fit-out, a finishes refresh, a single-room equipment swap, a parking structure, or a standalone medical-office shell. Preconstruction adds fee and calendar time that a well-defined scope does not need.
The design is already complete and stable. If a full, biddable set exists and scope is unlikely to change, design-bid-build (DBB) will often capture a lower price through open hard-bid competition. CMAR's value is front-loaded collaboration the owner would not be using.
Statute forces low-bid award. Some public owners (certain states, counties, and authorities) are still constrained to lowest-responsible-bid procurement, or have only recently been granted CMAR authority. Where best-value/qualifications-based selection is not legally available, DBB may be the only compliant path. (Procurement and selection law are treated in the Procurement-Path Article.)
The owner wants single-point design-and-build accountability and is willing to cede design control. That is the design-build value proposition, not CMAR's.
The owner has thin staff and seeks maximum collaboration and shared risk. Integrated Project Delivery (IPD) — multi-party agreement, shared risk/reward pool — pushes further than CMAR on collaboration, though it demands sophisticated owner participation and a mature partner team.

Trade-offs the owner accepts by choosing CMAR

No delivery model is free of compromise. Choosing CMAR means accepting these trade-offs with eyes open:

Benefit CMAR delivers	The trade-off that comes with it
Early cost certainty via a GMP	The GMP is set before design is complete, so it rests on assumptions, allowances, and clarifications — scope gaps can surface as change orders later.
Builder input during design (constructability, cost, schedule)	The owner pays preconstruction fees and adds calendar time up front before any field work starts.
Owner keeps a direct A/E relationship and design control	The owner sits between two contracts and must actively manage the design–construction interface; the CM does not own the design risk that a design-builder would.
Qualifications-based CM selection (best value, not low bid)	The owner forgoes the price discovery of open hard-bid competition and must run a more involved, judgment-heavy selection.
Open-book GMP with defined contingencies and shared savings	"Open book" only works with real owner cost oversight; without disciplined review of contingency use, allowance reconciliation, and savings sharing, the cost advantage erodes.
Phased/early-release packages compress schedule	Starting construction before design is finished increases the chance of rework if early packages are released on immature design.

Two trade-offs deserve emphasis in healthcare specifically. First, the GMP-timing tension: the earlier the GMP is locked for budget certainty, the more it rests on incomplete documents — and healthcare scope (equipment selections, infection-control requirements, AHJ and accreditation-driven changes from CMS Conditions of Participation, TJC or DNV survey readiness) is unusually prone to late movement. Second, the interface-management burden: because design risk stays with the A/E and construction risk with the CM, the owner owns the seam between them. A capable owner's representative or program manager is often what makes CMAR succeed.